Amicus Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
FOLD Nasdaq 2830 amicusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amicus Therapeutics, Inc.

Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Apr 24th, 2025 2:01 pm
Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Apr 23rd, 2025 4:57 pm
Amicus Therapeutics to Report Q1 Earnings: What's in the Cards? - Apr 23rd, 2025 1:25 pm
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025 - Apr 21st, 2025 11:00 am
Is ​​Amicus Therapeutics, Inc. (FOLD) the Best Low Priced Growth Stock To Invest In? - Apr 11th, 2025 12:21 pm
Analysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven Soon - Apr 10th, 2025 11:29 am
Is Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires? - Apr 8th, 2025 2:06 pm
Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue? - Mar 21st, 2025 3:30 pm
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio - Mar 21st, 2025 2:10 pm
Is Amicus Therapeutics Inc. (FOLD) the Best Nasdaq Stock Under $20 to Buy Now? - Mar 17th, 2025 7:37 pm
Amicus Therapeutics, Inc. (FOLD): Among the Stocks Under $10 With High Upside Potential - Mar 12th, 2025 11:29 pm
US High Growth Tech Stocks With Strong Potential - Feb 28th, 2025 5:09 pm
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Feb 27th, 2025 12:00 pm
Why Amicus Therapeutics, Inc. (FOLD) is the Most Oversold Pharma Stock to Buy According to Analysts - Feb 23rd, 2025 6:30 pm
FOLD's Q4 Earnings Miss, Higher Product Sales Drive Revenue Growth - Feb 20th, 2025 3:37 pm
Compared to Estimates, Amicus Therapeutics (FOLD) Q4 Earnings: A Look at Key Metrics - Feb 20th, 2025 2:30 pm
Amicus Therapeutics Full Year 2024 Earnings: EPS Beats Expectations - Feb 20th, 2025 10:46 am
Amicus Therapeutics Inc (FOLD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Feb 20th, 2025 7:05 am
Q4 2024 Amicus Therapeutics Inc Earnings Call - Feb 20th, 2025 7:03 am
Amicus Therapeutics (FOLD) Q4 Earnings and Revenues Miss Estimates - Feb 19th, 2025 1:30 pm